Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.2850
-0.0134 (-4.49%)
At close: Nov 19, 2025, 4:00 PM EST
0.2851
+0.0001 (0.04%)
Pre-market: Nov 20, 2025, 5:32 AM EST
APLT's stock price has decreased by -96.71% in the past year and price targets may not have had time to catch up.
Applied Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$4.13
Upside
+1,349.12%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +426.32% | May 14, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +426.32% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +601.75% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +2,707.02% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +1,654.39% | Nov 29, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +1,303.51% | Nov 29, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +4,461.40% | Nov 27, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +3,759.65% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +4,812.28% | Sep 19, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +2,707.02% | Aug 27, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 31, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Jul 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +4,110.53% | Apr 11, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $12 | Buy | Initiates | $12 | +4,110.53% | Mar 26, 2024 |
| UBS | UBS | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +4,461.40% | Mar 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.